Patent directory · USPTO A61K / A61P
Patents matching “ProQR Therapeutics II B.V.”
19 pharma patents match "ProQR Therapeutics II B.V." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 19 pharmaceutical patents matching "ProQR Therapeutics II B.V." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12275937
Stereospecific linkages in RNA editing oligonucleotides
granted -
US 12203072
Chemically modified single-stranded rna-editing oligonucleotides
granted -
US 12180471
Antisense oligonucleotides for the treatment of Stargardt disease
granted -
US 12018257
Single-stranded RNA-editing oligonucleotides
granted -
US 11920132
Oligonucleotide therapy for Leber congenital amaurosis
granted -
US 11851656
Chemically modified single-stranded RNA-editing oligonucleotides
granted -
US 11649454
Single-stranded RNA-editing oligonucleotides
granted -
US 11479771
Antisense oligonucleotides for the treatment of eye disease
granted -
US 11123360
Oligonucleotides to treat eye disease
granted -
US 10988763
Single-stranded RNA-editing oligonucleotides
granted -
US 10941402
Chemically modified single-stranded RNA-editing oligonucleotides
granted -
US 10900041
Antisense oligonucleotides for use in treating Alzheimer's disease
granted -
US 10889817
Oligonucleotide therapy for Leber Congenital Amaurosis
granted -
US 10760076
Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
granted -
US 10617707
Oligonucleotides to treat eye disease
granted -
US 10612025
Antisense oligonucleotides for the treatment of eye disease
granted -
US 10421963
Oligonucleotide therapy for leber congenital amaurosis
granted -
US 9994856
Method for increasing the activity of a cystic fibrosis transmembrane conductance regulator protein
granted -
US 9605255
Oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell
granted